Immunotherapy of metastatic renal cell cancer
- 1 November 1996
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 7 (9) , 887-900
- https://doi.org/10.1093/oxfordjournals.annonc.a010790
Abstract
S. H. Goey, J. Verweij, G. Stoter; Immunotherapy of metastatic renal cell cancer, Annals of Oncology, Volume 7, Issue 9, 1 November 1996, Pages 887–900, https:Keywords
This publication has 93 references indexed in Scilit:
- Continuous intravenous interleukin-2 infusion and subcutaneous interferon-α in metastatic renal cell carcinomaEuropean Journal Of Cancer, 1993
- Inpatient continuous-infusion interleukin-2 in 788 patients with cancer the national biotherapy study group experienceCancer, 1993
- Continuous infusion of recombinant interleukin-2 with or without autologous lymphokine activated killer cells for the treatment of advanced renal cell carcinomaEuropean Journal Of Cancer, 1992
- The role of IL-10 in crossregulation of TH1 and TH2 responsesImmunology Today, 1991
- An Acquired Chemotactic Defect in Neutrophils from Patients Receiving Interleukin-2 ImmunotherapyNew England Journal of Medicine, 1990
- Multiple actions of interleukin 6 within a cytokine networkImmunology Today, 1988
- ‘B-cell factors’ are pleiotropicImmunology Today, 1988
- Natural killer activity: the definition of a function rather than a cell typeImmunology Today, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985